Chen Xiao, Jiang Ming, Li Haiying, Wang Yang, Shen Haitao, Li Xiang, Zhang Yunhai, Wu Jiang, Yu Zhengquan, Chen Gang
Department of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, China.
Department of Neurosurgery, The First Affiliated Hospital of University of Science and Technology of China, 17 Lujiang Road, Hefei, 230001, China.
J Neuroinflammation. 2020 Jul 14;17(1):209. doi: 10.1186/s12974-020-01882-6.
Microglial activation-mediated neuroinflammation is a major contributor to early brain injury (EBI) after subarachnoid hemorrhage (SAH). MicroRNA-124 (miR-124) is the most abundant miRNAs in the central nervous system (CNS) and plays a vital role in microglial activation by targeting protein CCAAT-enhancer-binding protein α (C/EBPα). It has been reported that the CX3CL1/CX3CR1 axis is involved in the delivery of miR-124 from neurons to microglia.
An experimental rat SAH model was established by injecting autologous arterial blood into the prechiasmatic cistern, and cultured primary neurons and microglia were exposed to oxyhemoglobin to mimic SAH in vitro. We additionally exploited specific expression plasmids encoding CX3CL1 and CX3CR1.
We observed significant decreases in CX3CL1 and CX3CR1 in the brain tissues of SAH patients. We also observed decreases in the levels of CX3CL1 in neurons and CX3CR1 in microglia after SAH in rats. Moreover, microglia exhibited an activated phenotype with macrophage-like morphology and high levels of CD45 and major histocompatibility complex (MHC) class II after SAH. After overexpression of CX3CL1/CX3CR1, the level of CD45 and MHC class II and the release of inflammatory factors tumor necrosis factor α, interleukin 1α and complement 1q were significantly decreased. There was also increased neuronal degeneration and behavior dysfunction after SAH, both of which were inhibited by CX3CL1/CX3CR1 overexpression. Additionally, we found that the delivery of exosomal miR-124 from neurons to microglia was significantly reduced after SAH, accompanied by an increase in C/EBPα expression, and was inhibited by CX3CL1/CX3CR1 overexpression. In conclusion, the CX3CL1/CX3CR1 axis may play protective roles after SAH by promoting the delivery of exosomal miR-124 to microglia and attenuate microglial activation and neuroinflammation.
CX3CL1/CX3CR1 axis may be a potential intervention target for the inhibition of SAH-induced EBI by promoting exosome transport of miR-124 to microglia.
小胶质细胞激活介导的神经炎症是蛛网膜下腔出血(SAH)后早期脑损伤(EBI)的主要促成因素。微小RNA-124(miR-124)是中枢神经系统(CNS)中含量最丰富的微小RNA之一,通过靶向蛋白CCAAT增强子结合蛋白α(C/EBPα)在小胶质细胞激活中起重要作用。据报道,CX3CL1/CX3CR1轴参与了miR-124从神经元向小胶质细胞的传递。
通过将自体动脉血注入视交叉前池建立实验性大鼠SAH模型,并将培养的原代神经元和小胶质细胞暴露于氧合血红蛋白以在体外模拟SAH。我们还利用了编码CX3CL1和CX3CR1的特异性表达质粒。
我们观察到SAH患者脑组织中CX3CL1和CX3CR1显著降低。我们还观察到大鼠SAH后神经元中CX3CL1水平和小胶质细胞中CX3CR1水平降低。此外,SAH后小胶质细胞呈现出具有巨噬细胞样形态的激活表型,且CD45和主要组织相容性复合体(MHC)II类水平升高。CX3CL1/CX3CR1过表达后,CD45和MHC II类水平以及炎症因子肿瘤坏死因子α、白细胞介素1α和补体1q的释放显著降低。SAH后神经元变性和行为功能障碍也增加,两者均被CX3CL1/CX3CR1过表达所抑制。此外,我们发现SAH后从神经元向小胶质细胞的外泌体miR-124传递显著减少,同时C/EBPα表达增加,且被CX3CL1/CX3CR1过表达所抑制。总之,CX3CL1/CX3CR1轴可能通过促进外泌体miR-124向小胶质细胞的传递在SAH后发挥保护作用,并减轻小胶质细胞激活和神经炎症。
CX3CL1/CX3CR1轴可能是通过促进miR-124向小胶质细胞的外泌体转运来抑制SAH诱导的EBI的潜在干预靶点。